Company: TIPT
Filing Date: 2025-10-31
Form Type: DEFM14A
Source: 0001140361-25-039949
Chunk: 76

Company: TIPTREE INC.
Filing Date: 2025-10-31
Form: DEFM14A
Chunk 76
---
.

<div align='center'>37</div>

#### TABLE OF CONTENTS
Accordingly, if the Merger is not consummated, there can be no assurance as to the effect of these risks and opportunities on the future value of your shares of Tiptree common stock. If the Merger is not consummated, the Tiptree Board will continue to evaluate and review Tiptree’s business operations, properties, dividend policy and capitalization, among other things, make such changes as are deemed appropriate and continue to seek to enhance stockholder value. If the Merger is not approved by Tiptree stockholders, or if the Merger is not consummated for any other reason, there can be no assurance that any other transaction acceptable to Tiptree will be offered or that Tiptree’s business, prospects or results of operation will not be adversely impacted. See the sections of this proxy statement entitled “Risk Factors—The Merger is subject to the Tiptree stockholder approval and other closing requirements, and may not be completed as anticipated, or at all,” beginning on page 28 , and “Risk Factors—Even if the Merger is completed, we cannot provide any assurances that we will realize the financial benefits we currently anticipate from the Merger,” beginning on page 30 , for additional information.

Additionally, we may explore other strategic alternatives, including a sale of our interest in Fortegra to another party; however, there can be no assurances that any alternative transactions will be identified or completed. An alternative transaction may have terms that are less favorable to us than the terms of the proposed Merger, or we may be unable to reach agreement with any third party on an alternate transaction that we would consider to be reasonable. See the section of this proxy statement entitled “Risk Factors—If the proposed Merger is not completed, we may explore other potential transactions, but alternatives may be less favorable to us,” beginning on page 30 for additional information.

#### The Merger Consideration
At the Effective Time, by virtue of the Merger and without any action on the part of the holder thereof, (i) each share of Fortegra common stock issued and outstanding immediately prior to the Effective Time (other than (A) Appraisal Shares and (B) shares of Fortegra common stock that are held by Fortegra, any of its Subsidiaries or Merger Sub, if any, which in each case will be cancelled) will be converted into and thereafter evidence the right to receive, without interest